Small firm turns the tide on Prempro litigation 
By:
Sylvia Hsieh
Published: January 18, 2011
Tags: breast cancer, hormone replacement therapy, hormone replacement therapy litigation, HRT litigation, Prempro, Wyeth, Wyeth Pharmaceuticals
In the ongoing mass tort over the hormone replacement therapy drug Prempro, two small firms recently teamed up to break the defense winning streak in the trials.
Drug litigation in review 2010
By:
Tony Ogden
Published: January 4, 2011
Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth
Much like 2009, 2010 was a busy year for prescription drug suits.
HRT litigation rolls on
By:
Nora Tooher
Published: August 31, 2010
Tags: hormone replacement therapy litigation, Pfizer, Premarin, Prempro, Provera, Upjohn, Wyeth
With Pfizer and plaintiffs’ lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: it’s turning into one of the longest-running mass torts in U.S. history.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
